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Atenolol (ATN), chemically known as 2-{4-[2-
hydroxy-3-(propan-2-ylamino)propoxy]phen-
yl}acetamide (1) is a β1-selective (cardioselective)
adrenoreceptor antagonist drug commonly used for
management of hypertension, prevention of heart
diseases as angina pectoris and control of some
forms of cardiac arrhythmia (2). It is also indicated
for prophylaxis of migraine. The drug is official in
Indian Pharmacopoeia (3), which describes a UV-
spectrophotometric method for the assay of ATN in
tablets whereas British Pharmacopoeia (4) describes
high performance liquid chromatographic (HPLC)
methods for its determination as official methods.
Other than these official methods, several methods
have been reported for the determination of ATN in
pharmaceutical dosage forms, which include diffuse
reflectance spectroscopy (2), liquid chromatography
(LC) (5ñ26), HPTLC (27), ultra performance liquid
chromatography (UPLC) (28), gas chromatography
(GC) (29, 30), non-supressed ion-chromatography
(31), fluorimetry (32, 33), differential scanning
calorimetry (DSC) and thermogravimetry (TG) (34),
electrophoresis (35ñ37), voltammetry (38), ion-
selective electrode (ISE) based potentiometry (39),
atomic absorption spectrometry (AAS) (40), UV-
spectrophotometry (41ñ49), visible spectrophotom-
etry (50ñ61) and titrimetry (59ñ61). 
To the best of our knowledge, there are twelve
reports on the use of visible spectrophotometry for
the determination of ATN in pharmaceuticals. The
reaction of ATN with hydroxylamine hydrochloride
in NaOH medium followed by the reaction of the
resultant hydroxamic acid derivative with FeCl3 to
give a red-violet ferric hydroxamate complex has
served as the basis of spectrophotometric assay
reported by Agrawal et al. (50). Assays based on
charge transfer complexation reaction of ATN with
choranilic acid have been reported by Agarwal et al.
(51) and Yu et al. (52). Korang et al. (53) have
developed a method based on the treatment of
CHCl3 extract of powdered tablets of atenolol with
acetaldehyde, a halogenated benzoquinone reagent
(chloranil, 2,5-dichlorobenzoquinone or 2,6-dibro-
mobenzoquinone chlorimine) and propan-2-ol. The
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Abstract: Three rapid, selective and sensitive spectrophotometric methods have been proposed for the quanti-
tative determination of atenolol (ATN) in pure form as well as in its pharmaceutical formulation. The methods
are based on charge transfer complexation reaction of ATN as n-electron donor with 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (DDQ), 2,4-dinitrophenol (DNP) and 2,4,6-trinitrophenol (picric acid; PA) as π-acceptors to
give highly colored radical anion species. The colored products were quantified spectrophotometrically at 590
nm with DDQ (method A) and at 420 nm with both DNP (method B) and PA (method C). Under the optimized
experimental conditions, Beerís law is obeyed over the concentration ranges of 3ñ48, 2ñ24 and 1.5ñ18 µg/mL
ATN for method A, method B and method C, respectively. The molar absorptivity, Sandell sensitivity, limits
of detection and quantification are also reported. The effects of reaction medium, reaction time and reagent con-
centration on the sensitivity and stability of the complexes formed have been examined. The proposed methods
were successfully applied to the determination of ATN in pure form and commercial tablets with good accura-
cy and precision. Statistical comparison of the results was performed using Studentís t-test and F-ratio at 95%
confidence level and the results showed no significant difference between the reference and proposed methods
with regard to accuracy and precision. Further, the accuracy and reliability of the methods were confirmed by
recovery studies via standard addition technique. 
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slow reaction between ATN and ammonium vana-
date in sulfuric acid medium resulted in two kinetic
spectrophotometric methods (fixed-concentration
method and fixed-time method) (54). Al-Ghannam
and Belal (55) used the reaction between ATN and
4-chloro-7-nitrobenzo-2-oxa-1,3-diazole in borate
buffer of pH 8 at the boiling temperature for the
kinetic spectrophotometric assay of the drug. The
method developed by Hiremath et al. (56) is based
on the oxidation of atenolol by a known excess of
permanganate in alkaline media and determination
of unreacted permanganate spectrophotometrically
at 526 nm. Bashir et al. (57) have reported a method
based on deamination of ATN in basic medium, fol-
lowed by addition of sodium nitroprusside to gener-
ate a colored complex. Basavaiah et al. (58) have
reported a method based on the oxidation of ATN by
a measured excess of chloramine-T followed by
determination of the unreacted oxidant by a charge-
transfer complexation reaction involving metol and
sulfanilic acid. The assay method based on the oxi-
dation of ATN by a known excess of chloramine-T
in acid medium followed by determination of the
unreacted oxidant by reacting with a fixed amount
of either, metanil yellow or indigo carmine have
been reported by Basavaiah et al. (59). A similar
method (60) employed bromate-bromide mixture,
methyl orange as reagents in acid medium. An acid-
base reaction employing phenol red has also been
reported by the same authors (61). 
However, many of the above methods suffered
from one or other disadvantages like poor sensitivi-
ty, heating or extraction step, use of expensive
chemical and/or complicated experimental setup as
can be seen from Table 1. 
Charge-transfer complexation is an important
phenomenon in biochemical and bioelectrochemial
energy transfer process (62). Charge transfer phe-
nomenon was introduced first by Mulliken. The
term charge transfer gives a certain type of complex
resulting from interactions of donor and acceptor
with the formation of weak bonds (63, 64) and dis-
cussed widely by Foster (65). Molecular interactions
between electron donors and acceptors are generally
associated with the formation of intensely colored
charge-transfer complexes which absorb radiation in
the visible region.
In the present study, ATN was found to react
with three π-acceptors, namely, 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ), 2,4-dinitrophe-
nol (DNP) and 2,4,6-trinitrophenol (picric acid; PA)
to form C-T complexes, based on which three sim-
ple, rapid, selective and sensitive spectrophotomet-
ric methods were developed for the determination of
ATN. The cited π-acceptors have earlier been
employed for the assay of several drug substances
(66ñ72) based on similar reaction.
EXPERIMENTAL
Instrument
A Systronics model 106 digital spectropho-
tometer (Systronics, Ahmedabad, Gujarat, India)
provided with 1 cm matched quartz cells was used
for all absorbance measurements.
Materials
Pharmaceutical grade atenolol (ATN) certified
to be 99.89% pure was received from Cipla India
Ltd., Mumbai, India. The following pharmaceutical
preparations were purchased from commercial
sources in the local market and subjected to analy-
sis: Atenex-25 (25 mg ATN per tablet) from Zydas
Healthcare, East Sikkim, India; Atekind-50 (50 mg
ATN per tablet) from Mankind Pharma Ltd., New
Delhi, India, and Aten-100 (100 mg ATN per tablet)
from Zydas Healthcare, East Sikkim, India.
Reagents and chemicals
All reagents used were of analytical reagent
grade and HPLC grade organic solvents were used
throughout the investigation. 
Solutions of 0.1% DDQ in 1,4-dioxane, 0.1%
DNP and 0.05% PA in dichloromethane were pre-
pared separately. A stock standard solution contain-
ing 100 µg/mL ATN was prepared by dissolving 10
mg of pure drug in acetonitrile and diluting to the
mark in a 100 mL calibrated flask with the same sol-
vent. The stock standard solution was diluted appro-
priately with acetonitrile to get the working concen-
trations of 60, 40 and 30 µg/mL ATN for use in
methods A, B and C, respectively. 
Construction of calibration curves
Method A (using DDQ)
Varying aliquots (0.25ñ4.0 mL) of a standard
ATN solution (60 µg/mL) were accurately transferred
into a series of 5 mL calibrated flasks using a micro
burette and the total volume in each flask was brought
to 4 mL by adding adequate quantity of acetonitrile.
To each flask, 1 mL of 0.1% DDQ solution was
added, the content was mixed well and the absorbance
was measured at 590 nm against a reagent blank sim-
ilarly prepared without adding ATN solution.
Method B (using DNP)
Different aliquots (0.25ñ3.0 mL) of standard
ATN solution (40 µg/mL) were accurately trans-
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Table 1. Comparison of the proposed and the existing visible spectrophotometric methods.
Linear range Reaction
No. Reagent/s Methodology λmax µg/mL and LOD, time, Remarks Ref.
used (nm) ε, L/mol cm µg/mL  min
1. Hydroxylamine Ferric hydroxamate 510 50ñ800 NR 20ñ30 Less sensitive, 48
hydrochloride- complex measured (ε = 5.3◊102) heating 
iron (III)   required
2. Chloranilic Charge transfer 534 25ñ250 NR - 49
acid  complex measured
3. Chloranilic Charge transfer 530 10ñ280 NA NA  50
acid  complex measured
4. Acetaldehyde 690 NA NA NA  51
-Chloranil
5. NH4VO3 Reaction rate 750 NA NA NA heating  52
measured required
6. 4-Chloro-7- Coupling product 460 5ñ50 1.3 30 heating  53
nitrobenzo-2- measured as a required
oxa-1,3-diazole function of time
7. Potassium Unreacted KMnO4 526 4 h Time-consuming, 54
permanganate- measured involve judicial
in alkaline medium  Rate-constant method 6.66ñ10.65 control of many
Fixed-concentration experimental
method 6.66ñ5.33 variables
Fixed-time method  6.66ñ7.99
8. Sodium Complex of 495 0.5ñ30 0.01 5 heating required 55
nitroprusside  ammonia (ε = 3.01◊105)
and nitroprusside 
was measured
9. Chloramine-T- Unreacted 520 2.5ñ25 2.34 20 Not selective, 56
metol- chloramine-T (ε = 3.24◊103) involves
sulfanilic acid was measured multiple
steps and
reactions 
10. Chloramine-T: Unreacted 57
a) Metanil chloramine-T 530 1ñ12 0.32 10 As above
yellow was measured (ε = 1.19◊104)
b) Indigo 610 2.5ñ20 0.04 10
carmine (ε = 6.65◊103) 
11. Bromate-bromide Unreacted 520 0.5ñ4.0 0.07 15 As above 58
mixture- methyl bromine (ε = 4.13◊104)
orange was measured
12. Phenol red The change 430 3.0ñ30 4.61 ñ  59
in the color (ε = 3.47◊103)
of phenol red 
was measured
13. a) DDQ Radical anion 590 3.0ñ48 0.26 ñ Rapid, simple, This
was measured (ε = 5.41◊103) sensitive selective work
b) 2,4-Dinitro- Charge transfer 420 2.0ñ24 0.23 ñ and no heating
phenol complex (ε = 1.13◊104) step. Use of one
c) Picric acid  measured 420 1.5ñ18 0.23 5 reagent and a
(ε = 1.13◊104) one step reaction
DDQ: 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, NR: Not reported, NA: Not available.
ferred into a series of 5 mL calibration flasks as
described above. One milliliter of 0.1% DNP solu-
tion was added to each flask and diluted to volume
with dichloromethane. The content was mixed well
and the absorbance was measured at 420 nm against
a reagent blank.
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Method C (using PA)
Aliquots (0.25ñ3.0 mL) of a standard ATN (30
µg/mL) solution were accurately transferred into a
series of 5 mL calibration flasks and the total vol-
ume was brought to 3 mL by adding acetonitrile. To
each flask, 1 mL of 0.05% PA solution was added
and the solution made up to volume with
dichloromethane. The content was mixed well and
the absorbance was measured at 420 nm against a
reagent blank.
Standard graph was prepared by plotting the
absorbance versus ATN concentration, and the con-
centration of the unknown was read from the cali-
bration graph or computed from the respective
regression equation.
Procedure for commercial tablets
Twenty tablets were weighed and pulverized.
An amount of tablet powder equivalent to 10 mg
ATN was extracted with three 30 mL portions of
acetonitrile. The extracts were filtered using
Whatman No. 42 filter paper; the filtrate was col-
lected in a 100 mL calibrated flask and diluted to
volume with acetonitrile. A suitable aliquot of the
filtrate (100 µg/mL ATN) was diluted to get the
working concentrations of 60, 40 and 30 µg/mL
ATN for analysis by methods A, B and C, respec-
tively, as described above. 
Procedure for the analysis of placebo blank and
synthetic mixture
A placebo blank containing starch (10 mg),
acacia (15 mg), hydroxylcellulose (10 mg), sodium
citrate (10 mg), talc (20 mg), magnesium stearate
(15 mg) and sodium alginate (10 mg) was made and
its solution was prepared as described under
ìProcedure for commercial tabletsî and then sub-
jected to analysis. 
A synthetic mixture was prepared by adding
pure ATN (50 mg) to the above mentioned placebo
blank and the mixture was homogenized. Synthetic
mixture containing 10 mg of ATN was weighed and
its solution was prepared as under ìProcedure for
commercial tabletsî. Two different aliquots were
subjected to analysis by the general procedure and
the concentration of ATN was found from the cali-
bration graph or from the regression equation.
RESULTS AND DISCUSSION
Absorption spectra
The reaction of ATN as n-electron donor and
the π-acceptors such as DDQ, DNP and PA results
in the formation of C-T complexes. The absorption
spectra of ATN-DDQ C-T complex resulted in the
formation of an intense reddish violet color whichFigure 1. Absorption spectra of ATN-DDQ CT-complex
Figure 2. Absorption spectra of ATN-DNP complex (method B) and ATN-PA complex (method C)
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exhibited three maxima at 590, 550 and 460 nm
(Fig. 1). These bands can be attributed to the forma-
tion of DDQ radical anions arising from the com-
plete transfer of n-electrons from donor to acceptor
moieties in acetonitrile. The absorption band at 590
nm was selected as analytical wavelength keeping in
view the sensitivity of the reaction product and
blank absorbance. Similarly, the reaction of ATN
with DNP or PA results in the formation of an
intense yellow product which exhibits absorption
maxima at 420 nm (Fig. 2).
Reaction mechanism
The chemistry used in method A is based on
the reaction of the basic nitrogen of ATN as n-donor
with DDQ as π-acceptor to form charge transfer
complex, which subsequently dissociates into radi-
cal anions depending on the polarity of the solvent
used (72). In polar solvents, such as acetonitrile,
complete electron transfer from the donor to the
acceptor moiety takes place with the formation of
intensely colored radical anions (Fig. 3) (73),
according to the following equation:
When an aromatic amine is combined with a polyni-
trophenol, one type of force field produces an acid-
base interaction, and the other, an electron donor-
acceptor interaction. The former interaction leads to
Figure 3. Probable mechanism for the formation of ATN-DDQ C-T complex
Figure 4. Probable mechanism for the formation of ATN-DNP and ATN-PA C-T complexes 
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the formation of true phenolate by proton-transfer,
and the latter, to a true molecular compound by
charge-transfer (74). Based on this, the mechanism
for method B and method C can be discussed in
terms of transfer of electronic charge from the ben-
zene ring of ATN, an electron-rich molecule (a
Lewis-base donor), to the ring of DNP or PA, an
electron-deficient molecule (a Lewis-acid acceptor),
and at the same time the proton of the hydroxyl
group of DNP or PA will transfer to the secondary
amine of ATN (Fig. 4). The explanation for the pro-
duced color in method B and method C lies in the
formation of complexes between the pairs of mole-
cules ATN-DNP and ATN-PA, and this complex
formation leads to the production of two new molec-
ular orbitals and, consequently, to a new electronic
transition (75).
Optimization of experimental variables
Many experimental variables, which found to
affect the color intensity and stability of the result-
ing complexes, were optimized to achieve maxi-
mum sensitivity and adherence to Beerís law. 
Effect of reagent concentration
The optimum concentration of the reagent
required to achieve maximum sensitivity for the
color developed in each method was ascertained by
adding different amounts of the reagent DDQ, DNP
or PA to a fixed concentration of ATN. The results
showed that 1.0 mL each of 0.1% DDQ, 0.1% DNP
and 0.05% PA solution was optimum for the pro-
duction of maximum and reproducible color intensi-
ty (Fig. 5). 
Effect of solvent
In order to select a suitable solvent for prepa-
ration of the reagent solutions used in the study, the
reagents were prepared separately in different sol-
vents such as 1,4-dioxane, chloroform, acetonitrile,
acetone, t-butanol, 2-propanol and dichloromethane,
and the reaction of ATN with DDQ, DNP or PA was
followed. In method A, as shown in Fig. 6, acetoni-
trile was best suited for preparation of DDQ solu-
tion. The dichloromethane solvent was found to be
the ideal solvent for preparation of both DNP and
PA for method B and method C, respectively (Fig.
6). Similarly, the effect of the diluting solvent was
studied for all methods and the results showed that
the ideal diluting solvent to achieve maximum sen-
sitivity was acetonitrile in method A and
dichloromethane in method B and method C.
Effect of reaction time and stability of the C-T
complexes
The optimum reaction times were determined
by measuring the absorbance of the complex formed
upon the addition of reagent solution to ATN solu-
tion at room temperature. The reaction of ATN with
DDQ in method A and DNP in method B was
instantaneous while complete color development
was attained after 5 min with PA. The absorbance of
the resulting C-T complexes remained stable for at
least 45 min for method A and for more than 24 h for
methods B and C. 
Figure 5. Effect of reagent concentration on the formation of
ATN-DDQ complex, (24 µg/mL ATN), ATN-DNP complex, (12
µg/mL ATN) and ATN-PA complex, (9 µg/mL ATN)
Figure 6. Effect of solvents on the formation of ATN-DDQ com-
plex, (24 µg/mL ATN), ATN-DNP complex, (20 µg/mL ATN) and
ATN-PA complex, (9 µg/mL ATN)
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Method validation 
The proposed methods were validated for lin-
earity, sensitivity, selectivity, accuracy, precision,
robustness, ruggedness and recovery according to
the current ICH guidelines (76).
Linearity and sensitivity
Under the optimum conditions, a linear relation
was obtained between absorbance and concentration
of ATN in the ranges given in Table 2. The calibra-
tion graph in each instance is described by the equa-
tion: Y = a + b X, (where Y = absorbance, a = inter-
cept, b = slope and X = concentration in µg/mL). The
correlation coefficient, intercept and slope for the cal-
ibration data are summarized in Table 2. Sensitivity
parameters such as apparent molar absorptivity and
Sandellís sensitivity values, the limits of detection
(LOD) and quantification (LOQ) are calculated as per
the current ICH guidelines (76) and compiled in
Table 2. LOD and LOQ were calculated according to
the same guidelines using the following formulae:
3.3σ 10σ
LOD = ññññññ    and    LOQ = ññññññs                                  s
where σ is the standard deviation of six reagent
blank determinations and s is the slope of the cali-
bration curve.
Table 2. Regression and analytical parameters. 
Parameter Method A Method B Method C 
λmax (nm) 590 420 420  
Beerís law limits (µg/mL) 3ñ48 2ñ24 1.5ñ18  
Molar absorptivity (L/mol cm) 5.41◊103 1.13◊104 1.13◊104
Sandell sensitivity* (µg/cm2) 0.0493 0.0236 0.0236  
Limit of detection (µg/mL) 0.26 0.23 0.23  
Limit of quantification (µg/mL) 0.80 0.70 0.69  
Regression equation, Y**
Intercept (a) 0.0091 0.0387 ñ0.0120
Slope (b) 0.0197 0.0387 0.0446
Correlation coefficient (r) 0.9992 0.9997 0.9999
Standard deviation of intercept (Sa) 0.01078 0.00650 0.00287
Standard deviation of slope (Sb) 0.00040 0.00045 0.00026
*Limit of determination as the weight in µg/mL of solution, which corresponds to an absorbance of A = 0.001 measured in a cuvette of
cross-sectional area 1 cm2 and l = 1 cm. 
**Y = a + bX, where Y is the absorbance, a is the intercept, b is the slope and X is the concentration in µg/mL.
Table 3. Evaluation of intra-day and inter-day precision and accuracy.
Intra-day (n = 7) Inter-day (n = 5)
ATN ATN ATN
Method taken founda %RSDb %REc founda %RSDb %REc
(µg/mL) (µg/mL) (µg/mL) 
12.00 11.83 1.31 1.41 12.24 1.56 2.04   
A 24.00 23.81 0.78 0.81 24.42 0.97 1.75   
36.00 35.65 1.06 0.98 36.66 1.28 1.84  
8.00 8.19 1.23 2.37 8.23 1.66 2.85   
B 12.00 12.11 1.01 0.90 12.29 2.01 2.42  
16.00 16.17 0.71 1.07 16.38 1.85 2.39  
6.00 5.91 0.57 1.47 6.13 1.74 2.18   
C 9.00 9.14 0.25 1.55 9.23 1.36 2.56   
12.00 11.79 0.82 1.72 12.29 1.54 2.38 
a Mean value of five determinations; b Relative standard deviation (%); c Relative error (%).
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Accuracy and precision
In order to determine the accuracy and preci-
sion of the proposed methods, pure drug (ATN)
solution at three different concentration levels (with-
in the working range) were prepared and analyzed in
seven replicates during the same day (intra-day pre-
cision) and on five consecutive days (inter-day pre-
cision) and the results are presented in Table 3. The
percentage relative error (RE%) was = 2.85 which
indicates that the accuracy of the methods is satis-
factory. Percentage relative standard deviation
(RSD %) for intra-day was = 1.23 and for inter-day
it was ≤ 2.01 indicating repeatability and usefulness
of the proposed methods in the routine analysis.
Selectivity
The selectivity of the proposed methods for the
analysis of ATN was evaluated by placebo blank
and synthetic mixture analyses. The recommended
procedures were applied to the analysis of placebo
blank and the resulting absorbance readings in all
methods were the same as that of the reagent blank,
confirming no interference from the placebo. The
analysis of synthetic mixture solution prepared as
described earlier yielded percent recoveries of 98.3
± 2.13, 99.1 ± 1.76 and 98.9 ± 1.91 (n = 5) for
method A, method B and method C, respectively.
The results of this study showed that the inactive
ingredients did not interfere in the assay indicating
the high selectivity of the proposed method and
applicability to use for routine determination in pure
and in tablets form.
Robustness and ruggedness
To evaluate the robustness of the methods, two
important experimental variables: volume of reagent
Table 4. Robustness and ruggedness.
Method robustness 
Method ruggedness
Parameters altered
Method ATN Reagent Reaction Inter-analysts Inter-instruments
taken volume, mLa timeb RSD, % RSD, %
µg/mL   RSD, % (n = 3) RSD, % (n = 3) (n = 3) (n = 3)  
12.00 0.56 1.24 2.48   
A 24.00 1.24 0.85 2.75   
36.00 1.35 0.63 2.16  
8.0 1.08 1.45 1.67   
B 12.0 1.26 1.38 2.39   
16.0 1.48 1.13 1.86  
6.0 0.79 1.45 0.75 2.75   
C 9.0 0.57 1.03 1.36 2.18   
12.0 1.14 0.94 1.12 1.67  
a In all methods, the volume of reagent was 0.8, 1.0 and 1.2 mL. b The reaction was instantaneous in methods A and B and the reaction
time was 4, 5 and 6 min for method C.
Table 5. Results of analysis of tablets by the proposed methods.
Found (percent of label claim ± SD)a
Tablet brand Label claim Reference Proposed methods
name mg/tablet method Method A Method B Method C
99.06 ± 1.17 99.82 ± 1.37 98.97 ± 1.32
Atenex-25  25 100.3 ± 0.58 t = 2.12 t = 0.72 t = 2.00
F = 4.07 F = 5.58 F = 5.18
98.21 ± 1.11 101.1 ± 1.06 98.31 ± 1.18
Atekind-50  50 99.67 ± 0.67 t = 2.52 t = 2.55 t = 2.24
F = 2.74 F = 2.50 F = 3.10
100.9 ± 1.91 101.5 ± 1.06 99.32 ± 1.71
Aten-100 100 100.6 ± 0.82 t = 0.32 t = 1.5 t = 1.51
F = 5.43 F = 1.67 F = 4.35
a Mean value of five determinations. Tabulated t-value at the 95% confidence level is 2.78. Tabulated F-value at the 95% confidence
level is 6.39. 
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in all the methods and reaction time in method C,
were altered incrementally and the effect of this
change on the absorbance of the C-T complexes was
studied. The results of this study are presented in
Table 4 and indicated that the proposed methods are
robust. Method ruggedness was evaluated by per-
forming the analysis following the recommended
procedures by three different analysts and on three
different spectrophotometers by the same analyst.
From the %RSD values presented in Table 4, one
can conclude that the proposed methods are rugged.
Application to analysis of tablets containing ATN
The proposed methods were successfully
applied to the determination of ATN in three brands
of tablets and the results are compiled in Table 5.
The results obtained were statistically compared
with those obtained by the reference method (3) by
applying the Studentís t-test for accuracy and F-test
for precision at 95% confidence level. As can be
seen from Table 5, the calculated t- and F- values at
95% confidence level did not exceed the tabulated
values of 2.78 and 6.39, respectively, for four
degrees of freedom. This indicates that there are no
significant differences between the proposed meth-
ods and the reference method with respect to accu-
racy and precision.
Recovery study
The accuracy and validity of the proposed
methods were further ascertained by performing
recovery studies. Pre-analyzed tablet powder was
spiked with pure ATN at three concentration levels
(50, 100 and 150 % of that in tablet powder) and the
total was analyzed by the proposed methods. The
results of this study are presented in Table 6 and
indicate that the excipients present in the tablets did
not interfere in the assay. 
CONCLUSIONS
This paper presents three visible spectrophoto-
metric methods for the quantitative determination of
atenolol in pure drug and tablets. The proposed
methods are based on charge-transfer complexation
reaction, and have the advantages of simplicity,
speed, accuracy and precision, and use of inexpen-
sive equipment compared to the reported chromato-
graphic methods. The reagents utilized in the pro-
posed methods are cheap, readily available and the
procedures do not involve any critical reaction con-
ditions or tedious sample preparation. Whereas most
of the reported methods rely on the use of multiple
reagents/reactions, the proposed methods employ a
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single reagent/reaction, with minimal manipulation
which results in considerably increased precision.
The DDQ method is less sensitive than both DNP
and PA methods as can be seen from the lower
molar absorptivity value. The methods are charac-
terized by wide linear dynamic ranges and high sen-
sitivity compared to many existing spectrophoto-
metric methods. Moreover, the proposed methods
are free from the usual analytical complications like
heating or extraction steps and can be performed at
room temperature. Thus, the proposed methods are
useful for the quality control and routine analysis of
ATN in pharmaceuticals because there is no inter-
ference from the common excipients usually found
in commercial tablets.
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